PROPHARMA GROUP MIS HOLDINGS LIMITED
Get an alert when PROPHARMA GROUP MIS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-28 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-10 (in 6mo)
Last made up 2025-10-27
Watchouts
None on the register
Cash
£9M
Latest balance sheet
Net assets
-£78M
Equity attributable
Employees
1,006
Average over period
Profit before tax
-£16M
Period ending 2024-12-31
Name history
Renamed 1 time since incorporation
- PROPHARMA GROUP MIS HOLDINGS LIMITED 2013-12-09 → present
- SHOO 588 LIMITED 2013-11-06 → 2013-12-09
Net assets
2-year trend · vs Technology median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £133,787,370 | £151,753,265 | |
| Operating profit | -£20,611,338 | -£9,972,784 | |
| Profit before tax | -£26,759,544 | -£16,087,100 | |
| Net profit | -£26,422,801 | -£18,634,034 | |
| Cash | £7,442,557 | £8,799,986 | |
| Total assets less current liabilities | £41,666,348 | £29,096,329 | |
| Net assets | -£62,330,077 | -£78,416,088 | |
| Equity | -£62,330,077 | -£78,416,088 | |
| Average employees | 1,046 | 1,006 | |
| Wages | £50,165,453 | £54,962,843 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -15.4% | -6.6% | |
| Net margin | -19.7% | -12.3% | |
| Return on capital employed | -49.5% | -34.3% | |
| Current ratio | 1.11x | 1.08x | |
| Interest cover | -3.33x | -1.62x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared forecasts for the period ending 12 months from the date of approval of these financial statements and obtained confirmation of support from the ultimate parent company for the same period. As a result, at the time of approval of the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in existence for at least 12 months from the date of approval of these financial statements. Thus, the directors continue to adopt the going concern basis of accounting in preparation of the financial statements.”
Group structure
- PROPHARMA GROUP MIS HOLDINGS LIMITED · parent
- Project Tulip TopCo Ltd 100%
- ProPharma Group Europe B.V. 100%
- ProPharma Group GK 100%
- ProPharma Group GmbH 100%
- ProPharma Group MIS Limited 100%
- ProPharma Group MIS PTY Limited 100%
- ProPharma Group Sweden AB 100%
- PropPharma Group Sweden Holding AB 100%
- ProPharma Group The Netherlands B.V. 100%
- ProPharma Group UK Ltd 100%
- Southwood Research Ltd 100%
- Diamond Compliance & Quality Limited 100%
- Diamond Biopharm Limited 100%
- Diamond PV Services Limited 100%
- Diamond PV Services Ireland Limited 100%
- Diamond Pharma Services BV 100%
- Diamond Pharma Services Ireland Limited 100%
- Diamond ROC Services Limited 100%
- Diamond ROC EOOD 100%
- SDPBC Limited 100%
- Diamond Pharma Services Inc. 100%
- Planet Pharma Group Limited 100%
- Digital Lab Consulting Limited 100%
- Clinres Farmacija d.o.o 100%
- Clinres Farmacija d.o.o Bosnia en Herzegovnia 100%
- Clinres Farmacija d.o.o - Serbia 100%
- Clinres Farmacija d.o.o shpk 100%
- Clinres Farmacija SRL 100%
- Clinres Farmacia Ltd - Georgia 100%
- Clinres Farmcia LTD - Bulgaria 100%
- Clinres Macadonia 100%
- Clinres Montenegro 100%
- Planet Pharma Group B.V. 100%
Significant events
- “The group's turnover increased to £151,753k (2023: £133,787k). Turnover increase was largely driven behind an acquisition of Clinres Famacija d.o.o where a full year's trading is included within 2024 as opposed to 1 month in 2023.”
- “The group recorded a pre-tax loss of £16,087k, (2023: £26,760k) with the pre-tax loss decrease from the prior financial year driven from the increased turnover and resulting improved gross profit margin.”
- “Operating loss decreased by 51% to £9,973k in 2024 from £20,611k in 2023 as a result of the stabilised administration costs and increased gross profit as a result of the revenue increase detailed above. The business also recorded an exceptional cost (£3,027k) in 2023 relating to the impairment of a previously made acquisition in India.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 13 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARKER, Carl | Director | 2024-09-05 | Mar 1986 | British |
| DEGOES, Jason Jon | Director | 2021-02-15 | Nov 1969 | American |
Show 13 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEONANAN, Karl | Secretary | 2023-07-15 | 2024-08-28 |
| HARGROVES, Thomas Jeffrey | Secretary | 2013-11-28 | 2018-07-06 |
| SHERMAN, Dawn Gail | Secretary | 2018-07-06 | 2023-07-15 |
| SHOOSMITHS SECRETARIES LIMITED | Corporate Secretary | 2013-11-06 | 2013-11-28 |
| BAUWENS, Timothy Joseph | Director | 2021-07-02 | 2024-04-29 |
| CHESTNUT, Robert Hugh | Director | 2013-12-31 | 2021-07-02 |
| DEONANAN, Karl Vishnu | Director | 2023-07-15 | 2024-08-28 |
| FEAGANS, Derek Everett | Director | 2018-07-06 | 2018-10-31 |
| HARGROVES, Thomas Jeffrey | Director | 2013-11-28 | 2018-07-06 |
| HOFFMAN, Kirk | Director | 2013-12-31 | 2018-07-06 |
| LUIJENDIJK, Jan Johannes | Director | 2019-01-24 | 2021-03-01 |
| SADLER, Sian | Director | 2013-11-06 | 2013-11-28 |
| SHERMAN, Dawn Gail | Director | 2018-07-06 | 2023-07-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Thomas Jeffrey Hargroves | Individual | Significant influence | 2016-11-06 | Ceased 2018-07-06 |
| Propharma Mis Holdings Llc | Corporate entity | Shares 75–100% | 2016-11-06 | Active |
Filing timeline
Last 20 of 85 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-17 | AA | accounts | Accounts with accounts type group | |
| 2025-12-29 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-12-19 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-11-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-03 | AA | accounts | Accounts with accounts type group | |
| 2024-12-16 | AA01 | accounts | Change account reference date company previous shortened | |
| 2024-11-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-04 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-05-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-10 | AA | accounts | Accounts with accounts type group | |
| 2024-03-13 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-19 | AA01 | accounts | Change account reference date company previous shortened | |
| 2023-10-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-26 | CH03 | officers | Change person secretary company with change date | |
| 2023-10-26 | CH01 | officers | Change person director company with change date | |
| 2023-10-23 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-07-24 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-24 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31